RIYADH, Saudi Arabia & TOKYO--(BUSINESS WIRE)--Recursive Inc. (Headquarters: Shibuya-ku, Tokyo; CEO: Tiago Ramalho; hereinafter referred to as "Recursive"), a developer of AI solutions that facilitate ...

The artificial intelligence (AI) industry has been on a tear in the past two years, and judging by analyst estimates, it's just the beginning. AI-related sales will continue to soar in the coming ...

As of Wednesday, December 17, Recursion Pharmaceuticals, Inc.’s RXRX share price has surged by 13.10%, which has investors questioning if this is right time to sell.

An aptitude for mentally stringing together related items, often cited as a hallmark of human language, may have deep roots in primate evolution, a new study suggests. But “this work shows that the ...

Recursion Pharmaceuticals has a potentially revolutionary approach to developing drugs. However, the company has yet to produce enough clinical and regulatory wins to excite investors. Shares of the ...